Serbian President Aleksandar Vučić announced a package of measures aimed at easing household costs, including a reduction in the price of medicines effective 1 August and the commencement of one‑time assistance payments on 14 September. The United States simultaneously said it would temporarily lift tariffs on selected Serbian exports.
Medicine price cuts
According to the daily Novosti, the price reduction applies to a broad range of pharmaceuticals and will be implemented from the first day of August. The announcement was framed as “great news for citizens,” a phrase the outlet attributes directly to Vučić. The move follows months of public pressure over high out‑of‑pocket drug costs, which have been a recurring topic in Serbian domestic politics.
"Great news for citizens," Vučić said, according to Novosti.
The government has not released the exact percentage of the cuts, but officials indicated that the reductions will be “significant enough” to lower the financial burden on families that rely on chronic medication. Health‑care analysts note that price controls could also affect the profitability of domestic drug manufacturers, a trade‑off the administration appears prepared to accept in order to address public discontent.
One‑time assistance payments
The same set of announcements included details on a one‑time cash assistance program. KoSSev reported that payments will begin on 14 September, targeting individuals and households that meet eligibility criteria established by the Ministry of Labour, Employment, Veteran and Social Affairs. The assistance is intended to offset rising living costs, particularly in light of inflationary pressures that have affected food and energy prices.

While the exact amount per recipient was not disclosed, the government described the aid as “substantial” and said it would be distributed through existing social‑welfare channels to ensure rapid delivery. Critics have previously warned that such payments could be politically timed ahead of upcoming local elections, but the administration has dismissed any partisan interpretation, emphasizing the need to support vulnerable groups.
US tariff suspension
In a separate development, the news portal vijesti.me noted that the United States announced a temporary suspension of tariffs on certain Serbian goods. The move, described as “temporary,” is expected to benefit Serbian exporters of agricultural products and textiles, sectors that have struggled with reduced access to the American market in recent years.
U.S. officials did not specify the duration of the tariff relief, but the announcement coincides with Serbia’s broader effort to diversify its trade partnerships and improve its balance of payments. Analysts see the measure as a diplomatic gesture that could deepen economic ties between Belgrade and Washington, especially as Serbia pursues European Union accession while maintaining historic links with Russia.

Vučić, who has been Serbia’s president since 2017 and previously served as prime minister, commands a dominant position in the country’s political landscape. His government’s latest initiatives are part of a wider strategy to showcase tangible benefits to the electorate ahead of the 2026 parliamentary elections. The president’s dual focus on domestic welfare and foreign‑trade incentives reflects the balancing act Serbian leaders face between internal socioeconomic demands and external diplomatic engagements.
Opposition parties have not yet issued a coordinated response, but some lawmakers have called for greater transparency on the funding sources for the assistance program and the criteria used to set medicine price caps. International observers will be watching how effectively the announced measures translate into real‑world relief for Serbian citizens and whether the temporary US tariff suspension yields measurable gains for Serbia’s export sector.